These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23469954)

  • 21. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization.
    Bowman P; Haikala H; Paul RJ
    J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study.
    Cengiz SL; Erdi MF; Tosun M; Atalik E; Avunduk MC; Sönmez FC; Mehmetoglu I; Baysefer A
    Brain Inj; 2010; 24(6):877-85. PubMed ID: 20433288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
    Louhelainen M; Vahtola E; Kaheinen P; Leskinen H; Merasto S; Kytö V; Finckenberg P; Colucci WS; Levijoki J; Pollesello P; Haikala H; Mervaala EM
    Br J Pharmacol; 2007 Apr; 150(7):851-61. PubMed ID: 17325658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
    Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
    Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in vascular responses of the basilar artery to acetylcholine and endothelin-1 in an experimental rabbit vasospasm model.
    Kim CY; Paek SH; Seo BG; Kim JH; Han DH
    Acta Neurochir (Wien); 2003 Jul; 145(7):571-7. PubMed ID: 12910400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.
    Yokoshiki H; Katsube Y; Sunagawa M; Sperelakis N
    Eur J Pharmacol; 1997 Aug; 333(2-3):249-59. PubMed ID: 9314042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?
    Wanderer S; Andereggen L; Mrosek J; Kashefiolasl S; Schubert GA; Marbacher S; Konczalla J
    J Neurointerv Surg; 2022 Apr; 14(4):408-412. PubMed ID: 34039684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm.
    Vatter H; Konczalla J; Weidauer S; Preibisch C; Raabe A; Zimmermann M; Seifert V
    Neurosurgery; 2007 Jun; 60(6):1100-8; discussion 1108-9. PubMed ID: 17538385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage.
    Wanderer S; Mrosek J; Gessler F; Seifert V; Konczalla J
    Acta Neurochir (Wien); 2018 Feb; 160(2):277-284. PubMed ID: 29214400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and antiischaemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts.
    Rump AF; Acar D; Rösen R; Klaus W
    Pharmacol Toxicol; 1994; 74(4-5):244-8. PubMed ID: 8090694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties.
    Lehtonen LA
    Expert Opin Investig Drugs; 2001 May; 10(5):955-70. PubMed ID: 11322869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of potassium channels in the vasodilatory effect of levosimendan in human internal thoracic arteries.
    Usta C; Eksert B; Gölbasi I; Bigat Z; Ozdem SS
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):329-32. PubMed ID: 16829109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrovascular characterization of the novel nonpeptide endothelin-A receptor antagonist LU 208075.
    Vatter H; Zimmermann M; Weyrauch E; Lange BN; Setzer M; Raabe A; Seifert V
    Clin Neuropharmacol; 2003; 26(2):73-83. PubMed ID: 12671526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
    Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
    J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
    Kaheinen P; Pollesello P; Levijoki J; Haikala H
    J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of KATP-Channels, cAMP and cGMP.
    Rieg AD; Rossaint R; Verjans E; Maihöfer NA; Uhlig S; Martin C
    PLoS One; 2013; 8(6):e66195. PubMed ID: 23824760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.